Skip to main content
Springer logoLink to Springer
. 2010 Oct 28;27(4):573–577. doi: 10.1007/s10554-010-9735-8

Assessment of left ventricular function: visual or quantitative?

E E van der Wall 1,, J H C Reiber 1
PMCID: PMC3101355  PMID: 20981573

Assessment of cardiac function continues to be an important issue in patients with assumed left ventricular (LV) dysfunction [110]. In particular in patients with enlarged left ventricles, such as occurs in ischemic and idiopathic dilated cardiomyopathy, accurate assessment of LV function remains pivotal [1114]. To assess myocardial function, different diagnostic methods are currently performed such as echocardiography, single photon emission computed tomography (SPECT), and cardiac magnetic resonance imaging (CMR) [1523]. In the clinical arena, detection of myocardial function is predominantly based on echocardiographic studies. In addition, nuclear techniques, showing preserved tracer uptake and metabolism in viable myocardium, may also assess left ventricular function and wall motion. Volumetric analysis by gated SPECT imaging offers considerable additional value to SPECT myocardial perfusion imaging in characterizing functional abnormalities thereby potentially improving test specificity [2437]. Subsequent to echocardiography and gated SPECT imaging, CMR has now long been recognized as an accurate and reliable means of evaluating LV function. Considerable progress has been made in the field of CMR, providing accurate evaluation of LV function parameters in coronary artery disease, heart failure, hypertrophic cardiomyopathy, and many other cardiac diseases [3849]. CMR may be more accurate than echocardiography and gated SPECT in establishing LV volumetric parameters because of its more objective analysis and superb spatial resolution, respectively [5058].

In the current issue of the International Journal of Cardiovascular Imaging, Holloway et al. [59] nicely determined the accuracy of visual analysis of LV function in comparison with the accepted quantitative reference standard CMR. Cine CMR imaging was performed at 1.5 T on 44 patients with a range of LV ejection fractions (EF) between 5 and 80%. Eighteen clinicians were asked to visually assess LVEF after sequentially being shown cine images of a four-chamber (horizontal long axis), two-chamber (vertical long axis) and a short axis stack. The authors found strong correlations between visual and quantitative assessment. However, LVEF was underestimated in all categories (by 8.4% for horizontal long axis, 8.4% for horizontal long axis + vertical long axis and 7.9% for horizontal long axis + vertical long axis + short axis stack). LVEF was particularly underestimated in patients with mild LV dysfunction (17.4%, P < 0.01), less for moderate (4.9%) and not for severe impairment (1%). It was concluded that assessing more than one view of the heart improved visual assessment of LVEF. However, the 18 clinicians underestimated LVEF by 8.4% on average, with particular inaccuracy for those patients with mild LV dysfunction. Given the important clinical information provided by LV assessment, in particular in deformed left ventricles, the authors recommended quantitative analysis for accurate assessment of LV function.

Several studies have compared visual and quantitative assessment of LVEF, both in normal subjects and patients with impaired LV function [6068]. Nearly all studies showed that LVEF is underestimated by visual estimation compared with the quantitative assessment. Holman et al. [65], using a dedicated analytical software package (MASS version 1.0) including a modified centerline method and a new 3D-analysis approach, showed in 25 patients after acute myocardial infarction that the use of three-dimensional quantitative analysis of cine CMR images accurately quantifies the extent of regional LV dysfunction in the infarcted heart. Van der Geest et al. [66] evaluated a computer algorithm for the automated detection of LV endocardial and epicardial boundaries in time series of short-axis CMR images based on an Active Appearance Motion Mode. In 20 short-axis CMR examinations, manual contours were defined in multiple temporal frames (from end-diastole to end-systole) in multiple slices from base to apex. Global LV function results derived from automatically detected contours were compared with results obtained from manually traced boundaries. Automated contour detection resulted in small, but statistically non-significant, underestimations of LV volumes and mass: and an excellent agreement was observed in the LVEF. The fully automated contour detection method provided assessment of quantitative global LV function that is comparable to manual analysis, but offered the advantage of being more consistent, more reproducible, and less operator-dependent. Sievers et al. [67] investigated 100 subjects (40 normal subjects, 40 patients with ischemic cardiomyopathy, and 20 patients with nonischemic cardiomyopathy) using a 1.5-T CMR imager. LVEF was significantly underestimated by the visual reader in all 3 groups. The difference was larger in normal subjects than in patients with cardiomyopathy. The interobserver variability was smaller for the quantitative assessment than for the visual estimation. Attili et al. [69] reported that recent quantitation-oriented advances in CMR hardware and software have resulted in significant improvements in image quality and a reduction in imaging time.

To conclude, the study by Holloway et al. [59] confirms that the visual CMR approach for LVEF assessment may be used for rapid assessment of LV function in clinical practice where accuracy is of less concern. For an accurate analysis of LV function, the quantitative standard short axis approach is required.

Open Access

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Footnotes

Editorial comment to the article by Holloway et al. (doi: 10.1007/s10554-010-9706-0).

References

  • 1.Bax JJ, van der Wall EE, Harbinson M. Radionuclide techniques for the assessment of myocardial viability and hibernation. Heart. 2004;90(Suppl 5):v26–v33. doi: 10.1136/hrt.2002.007575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Bavelaar-Croon CD, Pauwels EK, van der Wall EE. Gated single-photon emission computed tomographic myocardial imaging: a new tool in clinical cardiology. Am Heart J. 2001;14:383–390. doi: 10.1067/mhj.2001.112780. [DOI] [PubMed] [Google Scholar]
  • 3.van der Wall EE, Heidendal GA, den Hollander W, Westera G, Roos JP. I-123 labeled hexadecenoic acid in comparison with Thallium-201 for myocardial imaging in coronary heart disease. A preliminary study. Eur J Nucl Med. 1980;5:401–405. doi: 10.1007/BF00261781. [DOI] [PubMed] [Google Scholar]
  • 4.Slart RH, Bax JJ, Sluiter WJ, van Veldhuisen DJ, Jager PL. Added value of attenuation-corrected Tc-99m tetrofosmin SPECT for the detection of myocardial viability: comparison with FDG SPECT. J Nucl Cardiol. 2004;11:689–696. doi: 10.1016/j.nuclcard.2004.06.131. [DOI] [PubMed] [Google Scholar]
  • 5.Ten Cate FJ. Cardiomyopathies: a revolution in molecular medicine and cardiac imaging. Neth Heart J. 2009;17:456–457. doi: 10.1007/BF03086303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.America YG, Bax JJ, Dibbets-Schneider P, Pauwels EK, Van der Wall EE. Evaluation of the Quantitative Gated SPECT (QGS) software program in the presence of large perfusion defects. Int J Cardiovasc Imaging. 2005;21:519–529. doi: 10.1007/s10554-005-0274-7. [DOI] [PubMed] [Google Scholar]
  • 7.van Eck-Smit BL, van der Wall EE, Kuijper AF, Zwinderman AH, Pauwels EK. Immediate thallium-201 reinjection following stress imaging: a time-saving approach for detection of myocardial viability. J Nucl Med. 1993;34:737–743. [PubMed] [Google Scholar]
  • 8.Groutars RG, Verzijlbergen JF, Tiel-van Buul MM, et al. The accuracy of 1-day dual-isotope myocardial SPECT in a population with high prevalence of coronary artery disease. Int J Cardiovasc Imaging. 2003;19:229–238. doi: 10.1023/A:1023637804898. [DOI] [PubMed] [Google Scholar]
  • 9.van der Wall EE, den Hollander W, Heidendal GA, Westera G, Majid PA, Roos JP. Dynamic myocardial scintigraphy with 123I-labeled free fatty acids in patients with myocardial infarction. Eur J Nucl Med. 1981;6:383–389. doi: 10.1007/BF00266427. [DOI] [PubMed] [Google Scholar]
  • 10.Braun S, van der Wall EE, Emanuelsson S, Kobrin I. Effects of a new calcium antagonist, mibefradil (Ro 40–5967), on silent ischemia in patients with stable chronic angina pectoris: a multicenter placebo-controlled study. The mibefradil international study group. J Am Coll Cardiol. 1996;27:317–322. doi: 10.1016/0735-1097(95)00472-6. [DOI] [PubMed] [Google Scholar]
  • 11.Portegies MC, Schmitt R, Kraaij CJ, et al. Lack of negative inotropic effects of the new calcium antagonist Ro 40–5967 in patients with stable angina pectoris. J Cardiovasc Pharmacol. 1991;18:746–751. doi: 10.1097/00005344-199111000-00013. [DOI] [PubMed] [Google Scholar]
  • 12.de Nooijer R, Verkleij CJ, von der Thüsen JH, et al. Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis. Arterioscler Thromb Vasc Biol. 2006;26:340–346. doi: 10.1161/01.ATV.0000197795.56960.64. [DOI] [PubMed] [Google Scholar]
  • 13.Hoogendoorn LI, Pattynama PM, Buis B, van der Geest RJ, van der Wall EE, de Roos A. Noninvasive evaluation of aortocoronary bypass grafts with magnetic resonance flow mapping. Am J Cardiol. 1995;75:845–848. doi: 10.1016/S0002-9149(99)80429-9. [DOI] [PubMed] [Google Scholar]
  • 14.van der Laarse A, Kerkhof PL, Vermeer F, et al. Relation between infarct size and left ventricular performance assessed in patients with first acute myocardial infarction randomized to intracoronary thrombolytic therapy or to conventional treatment. Am J Cardiol. 1988;61:1–7. doi: 10.1016/0002-9149(88)91294-5. [DOI] [PubMed] [Google Scholar]
  • 15.Bakx AL, van der Wall EE, Braun S, Emanuelsson H, Bruschke AV, Kobrin I. Effects of the new calcium antagonist mibefradil (Ro 40–5967) on exercise duration in patients with chronic stable angina pectoris: a multicenter, placebo-controlled study. Ro 40–5967 International Study Group. Am Heart J. 1995;130:748–757. doi: 10.1016/0002-8703(95)90073-X. [DOI] [PubMed] [Google Scholar]
  • 16.van Rugge FP, Boreel JJ, van der Wall EE, et al. Cardiac first-pass and myocardial perfusion in normal subjects assessed by sub-second Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr. 1991;15:959–965. doi: 10.1097/00004728-199111000-00010. [DOI] [PubMed] [Google Scholar]
  • 17.Nijveldt R, Beek AM, Hirsch A, et al. ‘No-reflow’ after acute myocardial infarction: direct visualisation of microvascular obstruction by gadolinium-enhanced CMR. Neth Heart J. 2008;16:179–181. doi: 10.1007/BF03086141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Bax JJ, Visser FC, van Lingen A, Cornel JH, Fioretti PM, van der Wall EE. Metabolic imaging using F18-fluorodeoxyglucose to assess myocardial viability. Int J Card Imaging. 1997;13:145–155. doi: 10.1023/A:1005744810876. [DOI] [PubMed] [Google Scholar]
  • 19.Underwood SR, Bax JJ, vom Dahl J, et al. Study group of the European society of cardiology. Imaging techniques for the assessment of myocardial hibernation. Report of a study group of the European society of cardiology. Eur Heart J. 2004;25:815–836. doi: 10.1016/j.ehj.2004.03.012. [DOI] [PubMed] [Google Scholar]
  • 20.Torn M, Bollen WL, van der Meer FJ, van der Wall EE, Rosendaal FR. Risks of oral anticoagulant therapy with increasing age. Arch Intern Med. 2005;165:1527–1532. doi: 10.1001/archinte.165.13.1527. [DOI] [PubMed] [Google Scholar]
  • 21.Slart RH, Bax JJ, van Veldhuisen DJ, van der Wall EE, Dierckx RA, Jager PL. Imaging techniques in nuclear cardiology for the assessment of myocardial viability. Int J Cardiovasc Imaging. 2006;22:63–80. doi: 10.1007/s10554-005-7514-8. [DOI] [PubMed] [Google Scholar]
  • 22.Slart RH, Bax JJ, van Veldhuisen DJ, et al. Prediction of functional recovery after revascularization in patients with chronic ischaemic left ventricular dysfunction: head-to-head comparison between 99mTc-sestamibi/18F-FDG DISA SPECT and 13N-ammonia/18F-FDG PET. Eur J Nucl Med Mol Imaging. 2006;33:716–723. doi: 10.1007/s00259-005-0016-z. [DOI] [PubMed] [Google Scholar]
  • 23.Bleeker GB, Holman ER, Steendijk P, et al. Cardiac resynchronization therapy in patients with a narrow QRS complex. J Am Coll Cardiol. 2006;48:2243–2250. doi: 10.1016/j.jacc.2006.07.067. [DOI] [PubMed] [Google Scholar]
  • 24.Ypenburg C, van der Wall EE, Schalij MJ, Bax JJ. Imaging in cardiac resynchronisation therapy. Neth Heart J. 2008;16:S36–S40. doi: 10.1007/BF03086204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Ypenburg C, Westenberg JJ, Bleeker GB, et al. Noninvasive imaging in cardiac resynchronization therapy—part 1: selection of patients. Pacing Clin Electrophysiol. 2008;31:1475–1499. doi: 10.1111/j.1540-8159.2008.01212.x. [DOI] [PubMed] [Google Scholar]
  • 26.van der Geest RJ, Niezen RA, van der Wall EE, de Roos A, Reiber JH. Automated measurement of volume flow in the ascending aorta using MR velocity maps: evaluation of inter- and intraobserver variability in healthy volunteers. J Comput Assist Tomogr. 1998;22:904–911. doi: 10.1097/00004728-199811000-00013. [DOI] [PubMed] [Google Scholar]
  • 27.Tops LF, Schalij MJ, Holman ER, van Erven L, van der Wall EE, Bax JJ. Right ventricular pacing can induce ventricular dyssynchrony in patients with atrial fibrillation after atrioventricular node ablation. J Am Coll Cardiol. 2006;48:1642–1648. doi: 10.1016/j.jacc.2006.05.072. [DOI] [PubMed] [Google Scholar]
  • 28.Oemrawsingh PV, Mintz GS, Schalij MJ, Zwinderman AH, Jukema JW, van der Wall EE. Intravascular ultrasound guidance improves angiographic and clinical outcome of stent implantation for long coronary artery stenoses: final results of a randomized comparison with angiographic guidance (TULIP Study) Circulation. 2003;107:62–67. doi: 10.1161/01.CIR.0000043240.87526.3F. [DOI] [PubMed] [Google Scholar]
  • 29.Bleeker GB, Bax JJ, Fung JW, et al. Clinical versus echocardiographic parameters to assess response to cardiac resynchronization therapy. Am J Cardiol. 2006;97:260–263. doi: 10.1016/j.amjcard.2005.08.030. [DOI] [PubMed] [Google Scholar]
  • 30.Bleeker GB, Schalij MJ, Boersma E, et al. Relative merits of M-mode echocardiography and tissue Doppler imaging for prediction of response to cardiac resynchronization therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 2007;99:68–74. doi: 10.1016/j.amjcard.2006.07.068. [DOI] [PubMed] [Google Scholar]
  • 31.Ypenburg C, Roes SD, Bleeker GB, et al. Effect of total scar burden on contrast-enhanced magnetic resonance imaging on response to cardiac resynchronization therapy. Am J Cardiol. 2007;99:657–660. doi: 10.1016/j.amjcard.2006.09.115. [DOI] [PubMed] [Google Scholar]
  • 32.Ypenburg C, Schalij MJ, Bleeker GB, et al. Extent of viability to predict response to cardiac resynchronization therapy in ischemic heart failure patients. J Nucl Med. 2006;47:1565–1570. [PubMed] [Google Scholar]
  • 33.Tops LF, Bax JJ, Zeppenfeld K, et al. Fusion of multislice computed tomography imaging with three-dimensional electroanatomic mapping to guide radiofrequency catheter ablation procedures. Heart Rhythm. 2005;2:1076–1081. doi: 10.1016/j.hrthm.2005.07.019. [DOI] [PubMed] [Google Scholar]
  • 34.Ypenburg C, Schalij MJ, Bleeker GB, et al. Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients. Eur Heart J. 2007;28:33–41. doi: 10.1093/eurheartj/ehl379. [DOI] [PubMed] [Google Scholar]
  • 35.Ypenburg C, Sieders A, Bleeker GB, et al. Myocardial contractile reserve predicts improvement in left ventricular function after cardiac resynchronization therapy. Am Heart J. 2007;154:1160–1165. doi: 10.1016/j.ahj.2007.07.035. [DOI] [PubMed] [Google Scholar]
  • 36.Molhoek SG, Bax JJ, van Erven L, et al. Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy. Am J Cardiol. 2004;93:860–863. doi: 10.1016/j.amjcard.2003.12.024. [DOI] [PubMed] [Google Scholar]
  • 37.Tio RA, Slart RH, de Boer RA, et al. Reduced regional myocardial perfusion reserve is associated with impaired contractile performance in idiopathic dilated cardiomyopathy. Neth Heart J. 2009;17:470–474. doi: 10.1007/BF03086306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.van der Wall EE, van Dijkman PR, de Roos A, et al. Diagnostic significance of gadolinium-DTPA (diethylenetriamine penta-acetic acid) enhanced magnetic resonance imaging in thrombolytic treatment for acute myocardial infarction: its potential in assessing reperfusion. Br Heart J. 1990;63:12–17. doi: 10.1136/hrt.63.1.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Holman ER, van Jonbergen HP, van Dijkman PR, van der Laarse A, de Roos A, van der Wall EE (1993) Comparison of magnetic resonance imaging studies with enzymatic indexes of myocardial necrosis for quantification of myocardial infarct size. Am J Cardiol 71:1036–1040 [DOI] [PubMed]
  • 40.van Rugge FP, Holman ER, van der Wall EE, de Roos A, van der Laarse A, Bruschke AV. Quantitation of global and regional left ventricular function by cine magnetic resonance imaging during dobutamine stress in normal human subjects. Eur Heart J. 1993;14:456–463. doi: 10.1093/eurheartj/14.4.456. [DOI] [PubMed] [Google Scholar]
  • 41.Sciagrà R, Leoncini M. Gated single-photon emission computed tomography. The present-day ‘‘one-stop-shop’’ for cardiac imaging. Q J Nucl Med Mol Imaging. 2005;49:19–29. [PubMed] [Google Scholar]
  • 42.Pluim BM, Lamb HJ, Kayser HW, Leujes F, et al. Functional and metabolic evaluation of the athlete’s heart by magnetic resonance imaging and dobutamine stress magnetic resonance spectroscopy. Circulation. 1998;97:666–672. doi: 10.1161/01.cir.97.7.666. [DOI] [PubMed] [Google Scholar]
  • 43.Pluim BM, Beyerbacht HP, Chin JC, et al. Comparison of echocardiography with magnetic resonance imaging in the assessment of the athlete’s heart. Eur Heart J. 1997;18:1505–1513. doi: 10.1093/oxfordjournals.eurheartj.a015479. [DOI] [PubMed] [Google Scholar]
  • 44.Pluim BM, Chin JC, De Roos A, et al. Cardiac anatomy, function and metabolism in elite cyclists assessed by magnetic resonance imaging and spectroscopy. Eur Heart J. 1996;17:1271–1278. doi: 10.1093/oxfordjournals.eurheartj.a015046. [DOI] [PubMed] [Google Scholar]
  • 45.Kurvers MJ, Braam RL, Verzijlbergen JF, Heestermans AA, Ten Berg JM. Myocardial salvage in STEMI patients treated with primary coronary angioplasty as demonstrated by myocardial SPECT. Neth Heart J. 2007;15:422–423. doi: 10.1007/BF03086044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Germans T, Nijveldt R, Brouwer WP, et al. The role of cardiac magnetic resonance imaging in differentiating the underlying causes of left ventricular hypertrophy. Neth Heart J. 2010;18:135–143. doi: 10.1007/BF03091752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Groenink M, Lohuis TA, Tijssen JG, et al. Survival and complication free survival in Marfan’s syndrome: implications of current guidelines. Heart. 1999;82:499–504. doi: 10.1136/hrt.82.4.499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.van Dijkman PR, van der Wall EE, de Roos A, et al. Acute, subacute, and chronic myocardial infarction: quantitative analysis of gadolinium-enhanced MR images. Radiology. 1991;180:147–151. doi: 10.1148/radiology.180.1.2052683. [DOI] [PubMed] [Google Scholar]
  • 49.van der Wall EE, Vliegen HW, de Roos A, Bruschke AV. Magnetic resonance imaging in coronary artery disease. Circulation. 1995;92:2723–2739. doi: 10.1161/01.cir.92.9.2723. [DOI] [PubMed] [Google Scholar]
  • 50.Vliegen HW, Doornbos J, de Roos A, Jukema JW, Bekedam MA, van der Wall EE. Value of fast gradient echo magnetic resonance angiography as an adjunct to coronary arteriography in detecting and confirming the course of clinically significant coronary artery anomalies. Am J Cardiol. 1997;79:773–776. doi: 10.1016/S0002-9149(96)00866-1. [DOI] [PubMed] [Google Scholar]
  • 51.Matheijssen NA, Louwerenburg HW, van Rugge FP, et al. Comparison of ultrafast dipyridamole magnetic resonance imaging with dipyridamole SestaMIBI SPECT for detection of perfusion abnormalities in patients with one-vessel coronary artery disease: assessment by quantitative model fitting. Magn Reson Med. 1996;35:221–228. doi: 10.1002/mrm.1910350214. [DOI] [PubMed] [Google Scholar]
  • 52.Atsma DE, Bavelaar-Croon CD, Germano G, et al. Good correlation between gated single photon emission computed myocardial tomography and contrast ventriculography in the assessment of global and regional left ventricular function. Int J Card Imaging. 2000;16:447–453. doi: 10.1023/A:1010611412958. [DOI] [PubMed] [Google Scholar]
  • 53.Bavelaar-Croon CD, Kayser HW, van der Wall EE, et al. Left ventricular function: correlation of quantitative gated SPECT and MR imaging over a wide range of values. Radiology. 2000;217:572–575. doi: 10.1148/radiology.217.2.r00nv15572. [DOI] [PubMed] [Google Scholar]
  • 54.Wahba FF, Lamb HJ, Bax JJ, et al. Assessment of regional myocardial wall motion and thickening by gated 99Tcm-tetrofosmin SPECT: a comparison with magnetic resonance imaging. Nucl Med Commun. 2001;22:663–671. doi: 10.1097/00006231-200106000-00010. [DOI] [PubMed] [Google Scholar]
  • 55.Bax JJ, Lamb H, Dibbets P, Pelikan H, et al. Comparison of gated single-photon emission computed tomography with magnetic resonance imaging for evaluation of left ventricular function in ischemic cardiomyopathy. Am J Cardiol. 2000;86:1299–1305. doi: 10.1016/S0002-9149(00)01231-5. [DOI] [PubMed] [Google Scholar]
  • 56.Matheijssen NA, Baur LH, Reiber JH, et al. Assessment of left ventricular volume and mass by cine magnetic resonance imaging in patients with anterior myocardial infarction intra-observer and inter-observer variability on contour detection. Int J Card Imaging. 1996;12:11–19. doi: 10.1007/BF01798113. [DOI] [PubMed] [Google Scholar]
  • 57.Persson E, Carlsson M, Palmer J, Pahlm O, Arheden H. Evaluation of left ventricular volumes and ejection fraction by automated gated myocardial SPECT versus cardiovascular magnetic resonance. Clin Physiol Funct Imaging. 2005;25:135–141. doi: 10.1111/j.1475-097X.2005.00599.x. [DOI] [PubMed] [Google Scholar]
  • 58.Ioannidis JP, Trikalinos TA, Danias PG. Electrocardiogram-gated single-photon emission computed tomography versus cardiac magnetic resonance imaging for the assessment of left ventricular volumes and ejection fraction: a meta-analysis. J Am Coll Cardiol. 2002;39:2059–2068. doi: 10.1016/S0735-1097(02)01882-X. [DOI] [PubMed] [Google Scholar]
  • 59.Holloway CJ, Edwards LM, Rider OJ et al. A comparison of visual and quantitative assessment of left ventricular ejection fraction by cardiac magnetic resonance. Int J Cardiovasc Imaging 2010 Oct 1 [Epub ahead of print] [DOI] [PubMed]
  • 60.van Rugge FP, van der Wall EE, Bruschke AV. New developments in pharmacologic stress imaging. Am Heart J. 1992;124:468–485. doi: 10.1016/0002-8703(92)90614-2. [DOI] [PubMed] [Google Scholar]
  • 61.van Rugge FP, van der Wall EE, van Dijkman PR, Louwerenburg HW, de Roos A, Bruschke AV (1992) Usefulness of ultrafast magnetic resonance imaging in healed myocardial infarction. Am J Cardiol 70:1233–1237 [DOI] [PubMed]
  • 62.van der Geest RJ, de Roos A, van der Wall EE, Reiber JH. Quantitative analysis of cardiovascular MR images. Int J Card Imaging. 1997;13:247–258. doi: 10.1023/A:1005869509149. [DOI] [PubMed] [Google Scholar]
  • 63.Matheijssen NA, de Roos A, Doornbos J, Reiber JH, Waldman GJ, van der Wall EE. Left ventricular wall motion analysis in patients with acute myocardial infarction using magnetic resonance imaging. Magn Reson Imaging. 1993;11:485–492. doi: 10.1016/0730-725X(93)90467-R. [DOI] [PubMed] [Google Scholar]
  • 64.Holman ER, Vliegen HW, van der Geest RJ, et al. Quantitative analysis of regional left ventricular function after myocardial infarction in the pig assessed with cine magnetic resonance imaging. Magn Reson Med. 1995;34:161–169. doi: 10.1002/mrm.1910340206. [DOI] [PubMed] [Google Scholar]
  • 65.Holman ER, Buller VG, de Roos A, et al. Detection and quantification of dysfunctional myocardium by magnetic resonance imaging. A new three-dimensional method for quantitative wall-thickening analysis. Circulation. 1997;95:924–931. doi: 10.1161/01.cir.95.4.924. [DOI] [PubMed] [Google Scholar]
  • 66.van der Geest RJ, Lelieveldt BP, Angelié E, et al. Evaluation of a new method for automated detection of left ventricular boundaries in time series of magnetic resonance images using an active appearance motion model. J Cardiovasc Magn Reson. 2004;6:609–617. doi: 10.1081/JCMR-120038082. [DOI] [PubMed] [Google Scholar]
  • 67.Sievers B, Kirchberg S, Franken U, Puthenveettil BJ, Bakan A, Trappe HJ. Visual estimation versus quantitative assessment of left ventricular ejection fraction: a comparison by cardiovascular magnetic resonance imaging. Am Heart J. 2005;150:737–742. doi: 10.1016/j.ahj.2004.11.017. [DOI] [PubMed] [Google Scholar]
  • 68.van der Wall EE, Bax JJ, Reiber JH. Cardiac magnetic resonance imaging analysis in STEMI: quantitative or still visual? Int J Cardiovasc Imaging. 2010 May 8. [Epub ahead of print] [DOI] [PMC free article] [PubMed]
  • 69.Attili AK, Schuster A, Nagel E, Reiber JH, van der Geest RJ. Quantification in cardiac MRI: advances in image acquisition and processing. Int J Cardiovasc Imaging. 2010;26(Suppl 1):27–40. doi: 10.1007/s10554-009-9571-x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The International Journal of Cardiovascular Imaging are provided here courtesy of Springer

RESOURCES